squamous cell carcinoma
Cervical Cancer Multiomic Study Uncovers Informative Intratumor Heterogeneity States
With single-cell, spatial, and experimental approaches, researchers defined eight "meta-programs" linked to the tumor immune microenvironment and clinical features.
The company reported that its Barrett's esophagus risk assay saw volumes more than triple in Q3 2023 compared to the same period last year.
Local Coverage Determinations Roundup: Castle Biosciences
Multiple Medicare Administrative Contractors aligned their non-coverage decisions for Castle Biosciences' DecisionDx-SCC test.
Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers
Researchers found four esophageal squamous cell carcinoma molecular subtypes by generating genomic, transcriptomic, epigenetic, and proteomic profiles for more than 150 cases.
DermTech Using $144M Financing to Spur Marketing, Telemedicine Efforts For Molecular Melanoma Assay
Premium
The firm expects to increase commercial coverage for its pigmented lesion assay for melanoma while widening its pipeline to diagnose other varieties of skin cancer.